Safety of influenza vaccines in pregnant women.

doi:10.1016/j.ajog.2012.06.072

Paper

DOI: 10.1016/j.ajog.2012.06.072

Safety of influenza vaccines in pregnant women.

Published Sep 1, 2012 · F. Muñoz

American journal of obstetrics and gynecology

Q1 SJR score

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Highly Cited

Study Snapshot

Influenza vaccines are safe for pregnant women and their infants, and can be effectively implemented through research, active surveillance, and education.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Full text analysis coming soon...

References

DOI: 10.1016/j.vaccine.2011.09.039

Inflammatory responses to trivalent influenza virus vaccine among pregnant women.

Trivalent influenza virus vaccination elicits a mild inflammatory response in pregnant women, which may predict risk of adverse perinatal health outcomes like preeclampsia and preterm birth.

2011·58citations·L. Christian et al.·Vaccine

Vaccine

DOI: 10.1016/j.ajog.2011.06.047

Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System.

Pregnant women receiving H1N1 vaccine showed no concerning patterns of maternal or fetal adverse events reported to VAERS.

2011·112citations·P. Moro et al.·American journal of obstetrics and gynecology

American journal of obstetrics and gynecology

DOI: 10.1093/infdis/jir440

Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women.

In pregnant women, a single dose of an inactivated 2009 H1N1 influenza vaccine containing 25 g of hemagglutinin effectively elicits an antibody response and effectively transfers antibody through the placenta.

2011·100citations·Lisa A. Jackson et al.·The Journal of infectious diseases

The Journal of infectious diseases

DOI: 10.1016/j.vaccine.2011.04.114

Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study.

Exposure to the AS03 adjuvanted H1N1 (2009) vaccine during pregnancy does not increase the risk of adverse pregnancy outcomes, congenital anomalies, preterm delivery, low birth weight neonates, or maternal complications.

2011·80citations·Fernanda Tavares et al.·Vaccine

Vaccine

DOI: 10.1016/j.ajog.2011.01.047

Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System.

The VAMPSS system effectively assesses the safety of influenza vaccines and antivirals during pregnancy, enhancing prevention and treatment by identifying potential risks and providing reassurance for relatively safe exposures.

2011·52citations·M. Schatz et al.·American journal of obstetrics and gynecology

American journal of obstetrics and gynecology

Citations

DOI: 10.3390/medicines11070018

Breathing for Two: Asthma Management, Treatment, and Safety of Pharmacological Therapy during Pregnancy

Pregnant women with asthma should continue using medications to maintain good asthma control and prevent exacerbations, as the benefits for both mother and fetus outweigh potential risks.

2024·0citations·J. Javorac et al.·Medicines

Medicines

DOI: 10.1080/21645515.2022.2106747

Adherence to and early adverse events of COVID-19 vaccine in a cohort of 600 Italian breastfeeding and pregnant physicians

Pregnant and breastfeeding women show reassurance in COVID-19 vaccine adherence and early adverse events, with mild side effects similar to those in the general population and after other vaccines.

2022·4citations·M. Montalti et al.·Human Vaccines & Immunotherapeutics

Human Vaccines & Immunotherapeutics

DOI: 10.1371/journal.pone.0265390

Knowledge attitudes and practices toward seasonal influenza vaccine among pregnant women during the 2018/2019 influenza season in Tunisia

Pregnant women in Tunisia show awareness of influenza vaccine but low uptake, with healthcare provider recommendations being the main reason for acceptance.

2022·7citations·S. Dhaouadi et al.·PLoS ONE

PLoS ONE

DOI: 10.1111/irv.12897

Exposure to quadrivalent influenza vaccine during pregnancy: Results from a global pregnancy registry

Exposure to quadrivalent influenza vaccine during pregnancy is safe, with no reported adverse maternal or neonatal outcomes.

2021·7citations·Shaleesa Ledlie et al.·Influenza and Other Respiratory Viruses

Influenza and Other Respiratory Viruses

DOI: 10.3389/fimmu.2021.704254

Associations Between Maternal Immunisation and Reduced Rates of Preterm Birth and Stillbirth: A Population Based Retrospective Cohort Study

Maternal immunization during pregnancy against influenza and pertussis is associated with reduced rates of stillbirth and preterm birth, as well as reduced odds of small-for-gestational age infants and preeclampsia.

2021·11citations·M. Giles et al.·Frontiers in Immunology

Frontiers in Immunology